Navigation Links
BiOptix to highlight new 404pi instrument at European symposia
Date:11/1/2012

BOULDER, Colo., AMSTERDAM and VIENNA, Nov. 1, 2012 /PRNewswire/ -- BiOptix today announced that it would be highlighting the new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology, at the Label Free Technologies Show in Amsterdam from November 1 - 3 as well as at the PEGS Europe Summit on November 6 – 8. 

"At the Label Free and PEGS Europe meetings, BiOptix will unveil new application data that demonstrates the value proposition of the upcoming BiOptix 404pi," noted Ken Wilczek, Vice President of Sales & Marketing for BiOptix.  "We are excited to demonstrate how BiOptix Enhanced or Phase-based SPR differs from standard surface plasmon resonance detection methods in that BiOptix technology combines the high sensitivity of SPR with the high stability and lower noise of common path interferometry—utilizing an internal reference for increased sensitivity."

BiOptix technology allows for the simultaneous monitoring of multiple analytes in a single sample.  This new class of SPR instrumentation from BiOptix has been designed to measure protein/protein and protein-small molecule interactions (down to 100 Da) in a high-throughput 96/384 well platform utilizing 4 parallel channels rather than a single flow cell.     

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix

BiOptix Diagnostics Corporation is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures and Rusnano.  BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at:  www.bioptix.com


'/>"/>
SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. BiOptix Participates in Leading Life Sciences Event BioWest 2012
2. BiOptix announces expansion of Board of Directors
3. AGU journal highlights -- 31 August 2012
4. Biomass characterization technology research highlighted in Industrial Biotechnology journal
5. Genetics Society of America’s GENETICS journal highlights for August 2012
6. AGU journal highlights -- 31 July 2012
7. New video series highlights the people who fuel Americas innovation pipeline
8. AGU Journal highlights -- July 16
9. Differences between human twins at birth highlight importance of intrauterine environment
10. Genetics Society of Americas Genetics journal highlights for July 2012
11. Highlighting molecular clues to the link between childhood maltreatment and later suicide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):
(Date:7/26/2017)... ... July 25, 2017 , ... Proscia Inc. , a software solutions provider ... panelist at 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer Goliath,” will ... emerging technology (AI, VR, Big Data) sectors are taking aim at cancer diagnosis and ...
(Date:7/26/2017)... Yorba Linda, Ca (PRWEB) , ... July 25, ... ... will host August 22, attendees will garner a better understanding of the considerations ... for HDR-mediated CRISPR-Cas9 applications. , The use of CRISPR-Cas9 to create targeted double-strand ...
(Date:7/26/2017)... ... July 26, 2017 , ... Spectral imaging is a ... day. This unique capability combines high resolution imaging with spectral analysis. ... unprecedented datasets for chemical analysis, quality control, and decision-making. , Snapshot spectral imaging ...
(Date:7/26/2017)... ... July 26, 2017 , ... Joni Rutter, Director ... Institutes of Health (NIH), will be one of the esteemed presenters at the ... for a multi-stakeholder discussion on the latest advancements in the precision and personalized ...
Breaking Biology Technology: